Insight Molecular Diagnostics (IMDX) Net Income towards Common Stockholders (QoQ) (2015 - 2026)
Insight Molecular Diagnostics (IMDX) Net Income towards Common Stockholders (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Insight Molecular Diagnostics | 158.03 Mn | 139.50 Mn | 157,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25.50% |
| Mar 31, 2026 | 60.42% |
| Dec 31, 2025 | -111.49% |
| Sep 30, 2025 | -11.41% |
| Jun 30, 2025 | -46.04% |
| Mar 31, 2025 | 80.09% |
| Dec 31, 2024 | -148.36% |
| Sep 30, 2024 | -194.16% |
| Jun 30, 2024 | 50.86% |
| Mar 31, 2024 | 29.65% |
| Dec 31, 2023 | -98.43% |
| Sep 30, 2023 | 22.64% |
| Jun 30, 2023 | -176,544.17% |
| Mar 31, 2023 | -99.95% |
| Dec 31, 2022 | 194.38% |
| Sep 30, 2022 | -14.99% |
| Jun 30, 2022 | 18.65% |
| Mar 31, 2022 | 71.32% |
| Dec 31, 2021 | -160.04% |
| Sep 30, 2021 | -31.52% |